Report DMCA Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case rep
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.